Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy

ABSTRACT: The purpose of the study is to assessed the efficiency of treatment based on the objective response rate (RECIST 1.1)

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2131358 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR